Effect of Calcium-vitamin D supplementation on serum lipids levels of 50-75 years old women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017020532406N1

Enrollment

100

Registered

2017-03-01

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidaemia. Hyperlipidaemia, unspecified

Interventions

The patients are given Calcium-vitamin D supplement tablets made by Tehran shimi pharmaceutical manufacturing Co. twice-daily (containing 500 mg calcium and 200 IU vitamin D) before breakfast and befo

Treatment - Drugs

Eligibility

Sex/Gender

Female

Age

50 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Not using calcium-vitamin D supplementation, normal thyroid hormone levels, satisfaction for participating in study. Exclusion criteria: underlying disease such as hyperlipidemia, diabetes, heart disease, atorvastatin consymption

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HDL. Timepoint: Baseline. Method of measurement: mg/dL.;LDL. Timepoint: Baseline. Method of measurement: mg/dL.;TG. Timepoint: Baseline. Method of measurement: mg/dL.;25 Hydroxy vitamin D. Timepoint: Baseline. Method of measurement: ng/mL.;BMI. Timepoint: Baseline. Method of measurement: kg/m2.;Waist circumference. Timepoint: Baseline. Method of measurement: cm.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Javadian, MD

Babol University of Medical Sciences

m.javadian@mubabol.ac.ir+98 11 2229 4718

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026